Cargando…
Immunosuppressive therapy to reduce mitral regurgitation in Libman–Sacks endocarditis: a case report
BACKGROUND: Libman–Sacks endocarditis is a cardiac manifestation of systemic lupus erythematosus (SLE) and is characterized by non-bacterial verrucous vegetations, causing valvular stenosis and/or regurgitation. The effectiveness of immunosuppressive therapy for valve dysfunction due to Libman–Sacks...
Autores principales: | Ishizu, Kenichi, Isotani, Akihiro, Yamaji, Kyohei, Ando, Kenji |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6764580/ https://www.ncbi.nlm.nih.gov/pubmed/31377769 http://dx.doi.org/10.1093/ehjcr/ytz133 |
Ejemplares similares
-
Surgical management of Libman-Sacks mitral valve endocarditis
por: Abouelela, Youssef, et al.
Publicado: (2021) -
Severe mitral regurgitation from Libman–Sacks endocarditis treated with MitraClip: a case report
por: Ningyan, Wong, et al.
Publicado: (2021) -
All Endocarditis Is Not Infective: Libman-Sacks Endocarditis
por: Al Riyami, Hilal, et al.
Publicado: (2022) -
Aortic valve replacement for Libman-Sacks endocarditis
por: Keenan, Jack B, et al.
Publicado: (2016) -
Libman-Sacks Endocarditis With Triple Valvular Involvement
por: Asher Syed, Meeran, et al.
Publicado: (2023)